Disarm Therapeutics
Latest round
- Series A
Last raised
- Sep 2017
Total raised
- $20M
Investors
- 3
About Disarm Therapeutics
Founded in 2016 and based in Massachusetts, US, Disarm Therapeutics, Inc. is a biotechnology company that develops drugs to treat patients with neurological diseases.
Who invested in Disarm Therapeutics
3 investors across 1 round
See all investors in Disarm Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 18, 2017
Amount
$20M
Investors
Questions about Disarm Therapeutics
Who invested in Disarm Therapeutics?
Disarm Therapeutics has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Disarm Therapeutics raised?
Disarm Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Disarm Therapeutics last raise money?
Disarm Therapeutics's most recent round on record is a Series A, in Sep 2017.
What does Disarm Therapeutics do?
Founded in 2016 and based in Massachusetts, US, Disarm Therapeutics, Inc.
Where is Disarm Therapeutics headquartered?
Disarm Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Disarm Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Disarm Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Disarm Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.